OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhostUNIVERSITÄT DORTMUND

Select item for more details and to access through your institution.

A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.
Published in:
Investigational New Drugs, 2018, v. 36, n. 1, p. 103, doi. 10.1007/s10637-017-0530-4
By:
- D’Angelo, Sandra P.;
- Hamid, Omid A.;
- Tarhini, Ahmad;
- Schadendorf, Dirk;
- Chmielowski, Bartosz;
- Collichio, Frances A.;
- Pavlick, Anna C.;
- Lewis, Karl D.;
- Weil, Susan C.;
- Heyburn, John;
- Schweizer, Charles;
- O’Shannessy, Daniel J.;
- Carvajal, Richard D.
Publication type:
Article
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
Published in:
2019
By:
- Jones, Robin L.;
- Chawla, Sant P.;
- Attia, Steven;
- Schöffski, Patrick;
- Gelderblom, Hans;
- Chmielowski, Bartosz;
- Le Cesne, Axel;
- Van Tine, Brian A.;
- Trent, Jonathan C.;
- Patel, Shreyaskumar;
- Wagner, Andrew J.;
- Chugh, Rashmi;
- Heyburn, John W.;
- Weil, Susan C.;
- Wang, Wenquan;
- Viele, Kert;
- Maki, Robert G.
Publication type:
journal article